D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.27% |
| 2 | Consumer Discretionary | 9.91% |
| 3 | Healthcare | 7.11% |
| 4 | Financials | 6.94% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
CALL
Organon & Co
OGN
$3.55B
| $230K | ﹤0.01% |
7,020
| – | – |
|
4352
Avita Medical
RCEL
$142M
| $230K | ﹤0.01% |
12,966
+2,969
| +30% | +$56K |
|
|
VOXX
4353
DELISTED
VOXX International Corporation Class A
VOXX
| $230K | ﹤0.01% |
20,073
-21,438
| -52% | -$245K |
|
|
VRS
4354
DELISTED
Verso Corporation
VRS
| $230K | ﹤0.01% |
11,063
-22,853
| -67% | -$441K |
|
|
RCOR
4355
DELISTED
Renovacor, Inc.
RCOR
| $229K | ﹤0.01% |
25,321
| – | – |
|
4356
Farmers National Banc Corp
FMNB
$899M
| $228K | ﹤0.01% |
14,486
+68
| +0.5% | +$1.04K |
|
4357
Edgewise Therapeutics
EWTX
$4.39B
| $227K | ﹤0.01% |
13,695
-32,472
| -70% | -$587K |
|
4358
Spyre Therapeutics
SYRE
$8.87B
| $227K | ﹤0.01% |
1,140
-699
| -38% | -$122K |
|
4359
German American Bancorp
GABC
$1.82B
| $226K | ﹤0.01% |
+5,846
| New | +$217K |
|
|
IAS
4360
DELISTED
Integral Ad Science
IAS
| $225K | ﹤0.01% |
+10,924
| New | +$215K |
|
|
NPTN
4361
DELISTED
NEOPHOTONICS CORP
NPTN
| $225K | ﹤0.01% |
+25,877
| New | +$236K |
|
4362
Natural Gas Services Group
NGS
$470M
| $224K | ﹤0.01% |
21,561
-2,845
| -12% | -$27.9K |
|
|
ORGN
4363
DELISTED
Origin Materials
ORGN
| $224K | ﹤0.01% |
1,098
-10,569
| -91% | -$2.18M |
|
|
AIFU
4364
AIFU Inc
AIFU
$201M
| $224K | ﹤0.01% |
46
-34
| -43% | -$189K |
|
4365
Allstate
ALL
$66.9B
| $223K | ﹤0.01% |
1,750
-7,555
| -81% | -$998K |
|
4366
Graham Corp
GHM
$1.22B
| $223K | ﹤0.01% |
17,972
-5,763
| -24% | -$74.4K |
|
|
TBIO
4367
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $222K | ﹤0.01% |
+1,108
| New | +$281K |
|
4368
Clarus
CLAR
$125M
| $221K | ﹤0.01% |
8,626
-31,365
| -78% | -$866K |
|
|
DM
4369
DELISTED
Desktop Metal, Inc.
DM
| $220K | ﹤0.01% |
+3,068
| New | +$266K |
|
4370
KBR
KBR
$4.68B
| $219K | ﹤0.01% |
5,547
-55,433
| -91% | -$2.15M |
|
4371
Pennant Group
PNTG
$1.43B
| $219K | ﹤0.01% |
+7,810
| New | +$255K |
|
4372
eGain
EGAN
$176M
| $218K | ﹤0.01% |
21,380
-9,764
| -31% | -$110K |
|
4373
The Joint Corp
JYNT
$119M
| $218K | ﹤0.01% |
2,229
-1,204
| -35% | -$113K |
|
|
RDFN
4374
DELISTED
Redfin
RDFN
| $218K | ﹤0.01% |
+4,361
| New | +$236K |
|
|
NESR
4375
National Energy Services Reunited Corp
NESR
$2.79B
| $218K | ﹤0.01% |
17,391
-81,429
| -82% | -$991K |
|
Similar funds
D.E. Shaw & Co's Q3 2021 Portfolio in Review
As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.
- D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.